SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZTC
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rocketman who wrote (313)6/8/1997 8:27:00 AM
From: Howard Williams   of 752
 
Thanks, Rman. For completeness I'm adding the final text from the article here since it's a quiet Sunday morning here on the front range.

<<The researchers kept the embryo cells that captured human chromosomes 14 and 22 - which together contain the genes necessary to make human antibodies - and implanted those cells into females.
The resulting newborns made human antibodies when the scientists gave them a shot of a foreign protein, showing that the transplanted genes
were working normally, the researchers report in the June issue of Nature Genetics.

CAN BE PASSED ON -
In separate experiments, the Japanese team showed that human chromosome pieces can in some cases be passed on to the offspring of humanized mice - a surprising finding because extra chromosomes typically interfere with reproduction.
Mice normally have 40 chromosomes, but those given human chromosomes 14 and 22 had a total of 42 (with the exception of one mouse in which one of the mouse chromosomes was mysteriously lost.)>>

Was (only mildly) surprised when I checked the VD Portfolio and found my lonely 2 biotech holdings are the top 2 $ holdings in your portfolio, CYTO and GZTC. Now I'm obligated to check the rest of your portfolio!

Still cruisin' the pathways of knowledge . . . . . . H.W.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News